InsiderTrades

Form 4 for KYMR Kymera Therapeutics, Inc.

Accepted 2026-04-16 18:30:03 ET · period of report 2026-04-14 · accession 0001193125-26-159538 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-04-16 18:30 2026-04-14+ KYMR Chadwick Jeremy G COO M - OptEx $34.41 +6,551 62.5K +12% +$225.4K
DMT 2026-04-16 18:30 2026-04-14+ KYMR Chadwick Jeremy G COO S - Sale+OE $90.00 -6,551 61.2K -10% -$589.6K
DMT 2026-04-16 18:30 2026-04-14+ KYMR Chadwick Jeremy G COO M - OptEx $0.00 -6,551 58.5K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-14 M A 4,466 $30.17 65,668 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
2 Common Common Stock 2026-04-14 M A 785 $43.50 66,453 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
3 Common Common Stock 2026-04-14 S D 5,251 $90.00 61,202 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4 Common Common Stock 2026-04-15 M A 1,300 $43.50 62,502 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
5 Common Common Stock 2026-04-15 S D 1,300 $90.00 61,202 D — — (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
6 Derivative Stock Option (Right to Buy) 2026-04-14 M D 4,466 $0.00 45,534 D $30.17 · — to 2035-03-02 4,466 Common Stock (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F3) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date.
7 Derivative Stock Option (Right to Buy) 2026-04-14 M D 785 $0.00 59,763 D $43.50 · — to 2034-02-28 785 Common Stock (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F4) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date.
8 Derivative Stock Option (Right to Buy) 2026-04-15 M D 1,300 $0.00 58,463 D $43.50 · — to 2034-02-28 1,300 Common Stock (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. (F4) The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date.